沈晓明:3月底博鳌或可打九价宫颈癌疫苗

2018-03-13 辛如记、朱永、许云 中国之声

海南博鳌超级医院3月底或运行,其中一个项目就是打疫苗,包括打预防宫颈癌的九价HPV疫苗。

今天,在中央人民广播电台两会特别节目《做客中央台》中,全国人大代表、海南省省长沈晓明在谈到海南医疗问题时透露,海南博鳌超级医院3月底或开始运行,其中一个项目就是打疫苗,包括打预防宫颈癌的九价HPV疫苗。


沈晓明表示,2013年国务院专门批准在海南博鳌建立国际旅游医疗先行区。“在美国、日本、欧盟等国家和地区已经批准的药和器械,在没有获得中国政府的批准以前,也可以经过一定的手续在这个地方使用,所以来海南也可以打九价HPV疫苗。”

据了解,目前全球已有3种HPV预防性疫苗获得美国食品与药品监督管理局批准上市,分别为二价HPV(含有HPV16和18型病毒L1蛋白)、四价HPV(含有6、11、16和18型病毒L1蛋白)和九价HPV(含有6、11、16、18、31、33、45、52和58型)疫苗。经国家食药监总局批准,我国目前可接种的是二价和四价HPV疫苗,而免疫性更强的九价HPV疫苗还没有在中国内地上市。

医学专业出身的沈晓明对海南医疗卫生事业发展也有自己独特的看法。“我国在医疗领域也存在‘马桶盖现象’(即消费者漂洋过海去国外买马桶盖)。据统计,2016年中国有60万人去国外求医问药,他们当中40%是恶性肿瘤、晚期肿瘤等重病,四分之一是体检,八分之一是整形美容。最近还有越来越多的人去国外打宫颈癌疫苗HPV。”

为什么大家都舍近求远去国外打疫苗呢?沈晓明指出,“不是我们疫苗打得不好,是因为在国外和中国香港已经能够用到九价HPV疫苗,国内还是四价疫苗,不是我们医生本事不大,而是我们的药和器械不够先进。”


万泉河畔正在建设的博鳌乐城国际医疗旅游先行区(图自《海南日报》)

沈晓明称,他认为海南作为全国唯一的省级经济特区,就应该用好这个特区,把健康产业作为今后一个重要的产业来发展。他希望海南医疗能够具有两个功能,“一个是为本地老百姓提供基本医疗服务,这个在现有的卫生体系中就应该解决;第二个是健康产业,海南是作为一个高端医疗服务业来发展的,这以博鳌乐城国际医疗旅游先行区为代表,今后它不仅仅是提供医疗服务,我们也希望它成为海南未来发展的支柱产业之一。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1690402, encodeId=797f1690402a7, content=<a href='/topic/show?id=3238364e0dc' target=_blank style='color:#2F92EE;'>#博鳌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36470, encryptionId=3238364e0dc, topicName=博鳌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b92129047523, createdName=fengyqf, createdTime=Mon Aug 13 05:34:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663754, encodeId=422f1663e5463, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Fri Feb 22 01:34:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967642, encodeId=575a196e642cc, content=<a href='/topic/show?id=838e644359b' target=_blank style='color:#2F92EE;'>#沈晓明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64435, encryptionId=838e644359b, topicName=沈晓明)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Wed Oct 17 00:34:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408105, encodeId=b594140810565, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Thu Mar 15 00:34:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296115, encodeId=056129611553, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI06MUzr7AI0nTlsgpDTRvVB51yAMdGfTKe8roX48ibEeqHD1dz3UibUa9SibU24UPLcEozJiaSB67WvQ/132, createdBy=fca0106828, createdName=Ramsey, createdTime=Wed Mar 14 08:46:33 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296114, encodeId=5d78296114a5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI06MUzr7AI0nTlsgpDTRvVB51yAMdGfTKe8roX48ibEeqHD1dz3UibUa9SibU24UPLcEozJiaSB67WvQ/132, createdBy=fca0106828, createdName=Ramsey, createdTime=Wed Mar 14 08:46:19 CST 2018, time=2018-03-14, status=1, ipAttribution=)]
    2018-08-13 fengyqf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1690402, encodeId=797f1690402a7, content=<a href='/topic/show?id=3238364e0dc' target=_blank style='color:#2F92EE;'>#博鳌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36470, encryptionId=3238364e0dc, topicName=博鳌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b92129047523, createdName=fengyqf, createdTime=Mon Aug 13 05:34:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663754, encodeId=422f1663e5463, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Fri Feb 22 01:34:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967642, encodeId=575a196e642cc, content=<a href='/topic/show?id=838e644359b' target=_blank style='color:#2F92EE;'>#沈晓明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64435, encryptionId=838e644359b, topicName=沈晓明)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Wed Oct 17 00:34:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408105, encodeId=b594140810565, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Thu Mar 15 00:34:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296115, encodeId=056129611553, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI06MUzr7AI0nTlsgpDTRvVB51yAMdGfTKe8roX48ibEeqHD1dz3UibUa9SibU24UPLcEozJiaSB67WvQ/132, createdBy=fca0106828, createdName=Ramsey, createdTime=Wed Mar 14 08:46:33 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296114, encodeId=5d78296114a5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI06MUzr7AI0nTlsgpDTRvVB51yAMdGfTKe8roX48ibEeqHD1dz3UibUa9SibU24UPLcEozJiaSB67WvQ/132, createdBy=fca0106828, createdName=Ramsey, createdTime=Wed Mar 14 08:46:19 CST 2018, time=2018-03-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1690402, encodeId=797f1690402a7, content=<a href='/topic/show?id=3238364e0dc' target=_blank style='color:#2F92EE;'>#博鳌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36470, encryptionId=3238364e0dc, topicName=博鳌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b92129047523, createdName=fengyqf, createdTime=Mon Aug 13 05:34:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663754, encodeId=422f1663e5463, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Fri Feb 22 01:34:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967642, encodeId=575a196e642cc, content=<a href='/topic/show?id=838e644359b' target=_blank style='color:#2F92EE;'>#沈晓明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64435, encryptionId=838e644359b, topicName=沈晓明)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Wed Oct 17 00:34:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408105, encodeId=b594140810565, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Thu Mar 15 00:34:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296115, encodeId=056129611553, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI06MUzr7AI0nTlsgpDTRvVB51yAMdGfTKe8roX48ibEeqHD1dz3UibUa9SibU24UPLcEozJiaSB67WvQ/132, createdBy=fca0106828, createdName=Ramsey, createdTime=Wed Mar 14 08:46:33 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296114, encodeId=5d78296114a5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI06MUzr7AI0nTlsgpDTRvVB51yAMdGfTKe8roX48ibEeqHD1dz3UibUa9SibU24UPLcEozJiaSB67WvQ/132, createdBy=fca0106828, createdName=Ramsey, createdTime=Wed Mar 14 08:46:19 CST 2018, time=2018-03-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1690402, encodeId=797f1690402a7, content=<a href='/topic/show?id=3238364e0dc' target=_blank style='color:#2F92EE;'>#博鳌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36470, encryptionId=3238364e0dc, topicName=博鳌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b92129047523, createdName=fengyqf, createdTime=Mon Aug 13 05:34:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663754, encodeId=422f1663e5463, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Fri Feb 22 01:34:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967642, encodeId=575a196e642cc, content=<a href='/topic/show?id=838e644359b' target=_blank style='color:#2F92EE;'>#沈晓明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64435, encryptionId=838e644359b, topicName=沈晓明)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Wed Oct 17 00:34:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408105, encodeId=b594140810565, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Thu Mar 15 00:34:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296115, encodeId=056129611553, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI06MUzr7AI0nTlsgpDTRvVB51yAMdGfTKe8roX48ibEeqHD1dz3UibUa9SibU24UPLcEozJiaSB67WvQ/132, createdBy=fca0106828, createdName=Ramsey, createdTime=Wed Mar 14 08:46:33 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296114, encodeId=5d78296114a5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI06MUzr7AI0nTlsgpDTRvVB51yAMdGfTKe8roX48ibEeqHD1dz3UibUa9SibU24UPLcEozJiaSB67WvQ/132, createdBy=fca0106828, createdName=Ramsey, createdTime=Wed Mar 14 08:46:19 CST 2018, time=2018-03-14, status=1, ipAttribution=)]
    2018-03-15 一闲
  5. [GetPortalCommentsPageByObjectIdResponse(id=1690402, encodeId=797f1690402a7, content=<a href='/topic/show?id=3238364e0dc' target=_blank style='color:#2F92EE;'>#博鳌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36470, encryptionId=3238364e0dc, topicName=博鳌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b92129047523, createdName=fengyqf, createdTime=Mon Aug 13 05:34:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663754, encodeId=422f1663e5463, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Fri Feb 22 01:34:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967642, encodeId=575a196e642cc, content=<a href='/topic/show?id=838e644359b' target=_blank style='color:#2F92EE;'>#沈晓明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64435, encryptionId=838e644359b, topicName=沈晓明)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Wed Oct 17 00:34:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408105, encodeId=b594140810565, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Thu Mar 15 00:34:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296115, encodeId=056129611553, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI06MUzr7AI0nTlsgpDTRvVB51yAMdGfTKe8roX48ibEeqHD1dz3UibUa9SibU24UPLcEozJiaSB67WvQ/132, createdBy=fca0106828, createdName=Ramsey, createdTime=Wed Mar 14 08:46:33 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296114, encodeId=5d78296114a5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI06MUzr7AI0nTlsgpDTRvVB51yAMdGfTKe8roX48ibEeqHD1dz3UibUa9SibU24UPLcEozJiaSB67WvQ/132, createdBy=fca0106828, createdName=Ramsey, createdTime=Wed Mar 14 08:46:19 CST 2018, time=2018-03-14, status=1, ipAttribution=)]
    2018-03-14 Ramsey

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1690402, encodeId=797f1690402a7, content=<a href='/topic/show?id=3238364e0dc' target=_blank style='color:#2F92EE;'>#博鳌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36470, encryptionId=3238364e0dc, topicName=博鳌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b92129047523, createdName=fengyqf, createdTime=Mon Aug 13 05:34:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1663754, encodeId=422f1663e5463, content=<a href='/topic/show?id=6a124631390' target=_blank style='color:#2F92EE;'>#宫颈癌疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46313, encryptionId=6a124631390, topicName=宫颈癌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=077725685033, createdName=12498adam48暂无昵称, createdTime=Fri Feb 22 01:34:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967642, encodeId=575a196e642cc, content=<a href='/topic/show?id=838e644359b' target=_blank style='color:#2F92EE;'>#沈晓明#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64435, encryptionId=838e644359b, topicName=沈晓明)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Wed Oct 17 00:34:00 CST 2018, time=2018-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408105, encodeId=b594140810565, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Thu Mar 15 00:34:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296115, encodeId=056129611553, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI06MUzr7AI0nTlsgpDTRvVB51yAMdGfTKe8roX48ibEeqHD1dz3UibUa9SibU24UPLcEozJiaSB67WvQ/132, createdBy=fca0106828, createdName=Ramsey, createdTime=Wed Mar 14 08:46:33 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296114, encodeId=5d78296114a5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI06MUzr7AI0nTlsgpDTRvVB51yAMdGfTKe8roX48ibEeqHD1dz3UibUa9SibU24UPLcEozJiaSB67WvQ/132, createdBy=fca0106828, createdName=Ramsey, createdTime=Wed Mar 14 08:46:19 CST 2018, time=2018-03-14, status=1, ipAttribution=)]
    2018-03-14 Ramsey

    学习了

    0

相关资讯

J Clin Oncol.:宫颈癌辅助化疗+手术VS. 放化疗:孰优孰劣?

2018年2月《JOURNAL OF CLINICAL ONCOLOGY》杂志在线发表一篇针对IB2- IIB期的宫颈鳞癌患者III期随机对照研究。尽管新辅助化疗加手术是目前临床治疗模式的主流选择,但仍缺乏足够确切的疗效证据。本研究对比了新辅助化疗+根治术与化放疗联合治疗方案的有效性和安全性。

四价宫颈癌疫苗在沪开打

从今天开始,上海市287家接种门诊和特需门诊将陆续提供四价宫颈癌疫苗接种服务。据了解,今年1月底,北京市民已经可以到家门口的社区卫生服务中心注射四价宫颈癌疫苗了。

HPV疫苗中国大战在即

继GSK与默沙东的战役打响后,一大批国产企业跃跃欲试,目前我国已有11家药企递交了HPV疫苗的临床申请,竞争日趋白热化。

JNCI:宫颈癌筛查:HPV 要不要联合细胞学检查?

宫颈癌筛查目前已经是发现宫颈癌前病变最常用的检查。相比细胞学检查,HPV在发现癌前病变方面的敏感性更优。

聚焦女性健康:关于HPV疫苗市场的那些事

致癌性高危HPV基因型的持续感染与宫颈癌的发生密切相关,而接种疫苗是预防HPV感染和发展为宫颈癌的最有效方法。

4价HPV疫苗红房子医院开打啦!

人乳头瘤病毒(HPV)是绝大多数宫颈癌的致病元凶,然而却没有什么特效药可以消灭它。不过自从人类发明了HPV疫苗用于预防HPV感染,最终可以达到预防宫颈癌的作用。